BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2021;59:5-30. [DOI: 10.47360/1995-4484-2021-5-30] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Nasonov EL, Soloviev SK, Arshinov AV. Systemic lupus erythematosus: history and modernity. Naučno-praktičeskaâ revmatologiâ 2022;60:397-412. [DOI: 10.47360/1995-4484-2022-397-412] [Reference Citation Analysis]
2 Baimukhamedov CT, Botabekova AK, Dossybayeva GN, Makhmudov SA. Rheumatoid arthritis and post-COVID-19 syndrome. Naučno-praktičeskaâ revmatologiâ 2022;60:276-279. [DOI: 10.47360/1995-4484-2022-276-279] [Reference Citation Analysis]
3 Kalenchic TI, Kabak SL, Korenevskaya IV. Autoantibodies and SARS-CoV-2 infection: A case report. Naučno-praktičeskaâ revmatologiâ 2022;60:271-275. [DOI: 10.47360/1995-4484-2022-271-275] [Reference Citation Analysis]
4 Baimukhamedov CT, Botabekova AK, Dossybayeva GN, Makhmudov SA. Rheumatoid arthritis and post-COVID-19 syndrome. Naučno-praktičeskaâ revmatologiâ 2022;60:276-279. [DOI: 10.47360/1995-4484-2022-276-279] [Reference Citation Analysis]
5 Eliseev MS, Zheliabina OV. Colchicine for the treatment of COVID-19: short path from theory to practice. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-11-71-79] [Reference Citation Analysis]
6 Beketova MF, Babak VV, Suprun MD, Beketova TV, Georginova OA. On the issue of post COVID-19 condition in patients with rheumatic diseases. Naučno-praktičeskaâ revmatologiâ 2022;60:162-164. [DOI: 10.47360/1995-4484-2022-162-164] [Reference Citation Analysis]
7 Sorotskaya VN, Plakhova AO, Halmuradova BB, Vaisman DS, Balabanova RM. Effect of COVID-19 coronavirus infection on the course of rheumatoid arthritis. Naučno-praktičeskaâ revmatologiâ 2022;60:157-161. [DOI: 10.47360/1995-4484-2022-157-161] [Reference Citation Analysis]
8 Nasonov EL, Korotaeva TV. Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology. Naučno-praktičeskaâ revmatologiâ 2022;60:131-148. [DOI: 10.47360/1995-4484-2022-131-148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Belov BS, Lila AM, Nasonov EL. Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues. Naučno-praktičeskaâ revmatologiâ 2022;60:21-31. [DOI: 10.47360/1995-4484-2022-21-31] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Nasonov EL, Lila AM, Dubinina TV, Nikininskaya OA, Amirdjanova VN. Advances in rheumatology at the beginning of the 21st century. Naučno-praktičeskaâ revmatologiâ 2022;60:5-20. [DOI: 10.47360/1995-4484-2022-5-20] [Reference Citation Analysis]
11 Borisova AB, Lisitsyna TA, Veltishchev DY, Nasonov EL. Anxiety, depression and stress tension screening in patients with rheumatic and musculoskeletal diseases at the onset of the 2019 coronavirus disease (COVID-19) pandemic. Naučno-praktičeskaâ revmatologiâ 2021;59:676-683. [DOI: 10.47360/1995-4484-2021-676-683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Nasonov EL, Feist E. Adult Still's disease: New horizons. Naučno-praktičeskaâ revmatologiâ 2021;59:645-665. [DOI: 10.47360/1995-4484-2021-643-663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Nasonov EL, Belov BS, Lila AM, Aronova ES, Gridneva GI, Kudryavtseva AV, Sokol EV, Torgashina AV, Vinogradova IB, Abdulganieva DI, Zimenko AY. Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review. Naučno-praktičeskaâ revmatologiâ 2021;59:666-675. [DOI: 10.47360/1995-4484-2021-666-675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
14 Drapkina OM, Shishkova VN, Berns SA, Gorshkov AY, Ryzhakova LN, Ivanova AA, Veretennikova AV. Vaccination against new coronavirus infection in patients with cardiovascular and autoimmune diseases. Kompleks probl serdečno-sosud zabol 2021;10:112-121. [DOI: 10.17802/2306-1278-2021-10-4-112-121] [Reference Citation Analysis]
15 Nasonov EL, Avdeeva AS. B cell depletion in immune-mediated rheumatic diseases and coronavirus disease 2019 (COVID-19). Naučno-praktičeskaâ revmatologiâ 2021;59:384-393. [DOI: 10.47360/1995-4484-2021-384-393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Mazurov VI, Belyaeva IB, Sarantseva LE, Chudinov AL, Bashkinov RA, Trofimov EA, Smulskaya OA, Inamova OV, Petrova MS, Melnikov ES. Impact of a new coronavirus infection on the clinical course of immunoinflammatory rheumatic diseases. HERALD of North-Western State Medical University named after I I Mechnikov 2021;13:39-47. [DOI: 10.17816/mechnikov72269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Nasonov EL, Lila AM, Mazurov VI, Belov BS, Karateev AE, Dubinina TV, Nikitinskaya OA, Baranov AA, Abdulganieva DI, Moiseev SV, Zagrebneva AI. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia. Naučno-praktičeskaâ revmatologiâ 2021;59:239-254. [DOI: 10.47360/1995-4484-2021-239-254] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 21.0] [Reference Citation Analysis]
18 Nasonov EL. 2019 Coronavirus disease (COVID-19): contribution of rheumatology. Terapevticheskii arkhiv 2021;93. [DOI: 10.26442/00403660.2021.05.200799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Nasonov EL, Popkova TV, Panafidina TA. Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic. Naučno-praktičeskaâ revmatologiâ 2021;59:119-128. [DOI: 10.47360/1995-4484-2021-119-128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]